Research output: Contribution to journal › Article › Academic › peer-review
National survey on the current practice and attitudes toward the management of chronic subdural hematoma. / Dutch Subdural Hematoma Research group collaboration.
In: Brain and behavior, Vol. 12, No. 3, e2463, 01.03.2022, p. e2463.Research output: Contribution to journal › Article › Academic › peer-review
}
TY - JOUR
T1 - National survey on the current practice and attitudes toward the management of chronic subdural hematoma
AU - Holl, Dana C.
AU - Blaauw, Jurre
AU - Ista, Erwin
AU - Dirven, Clemens M. F.
AU - Kho, Kuan H.
AU - Jellema, Korné
AU - van der Gaag, Niels A.
AU - Miah, Ishita P.
AU - den Hertog, Heleen M.
AU - van der Naalt, Joukje
AU - Jacobs, Bram
AU - Dutch Subdural Hematoma Research group collaboration
AU - Verbaan, Dagmar
AU - Polinder, Suzanne
AU - Lingsma, Hester F.
AU - Dammers, Ruben
N1 - Publisher Copyright: © 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - BACKGROUND: Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. However, evidence-based CSDH-guidelines are lacking and level I evidence from randomized clinical trials (RCTs) is limited. In order to establish and subsequently implement a guideline, insight into current clinical practice and attitudes toward CSDH-treatment is required. The aim is to explore current practice and attitudes toward CSDH-management in the Netherlands. METHODS: A national online survey was distributed among Dutch neurologists and neurosurgeons, examining variation in current CSDH-management through questions on treatment options, (peri)operative management, willingness to adopt new treatments and by presenting four CSDH-cases. RESULTS: One hundred nineteen full responses were received (8% of neurologists, N = 66 and 35% of neurosurgeons, N = 53). A majority of the respondents had a positive experience with burr-hole craniostomy (93%) and with a conservative policy (56%). Around a third had a positive experience with the use of dexamethasone as primary (30%) and additional (33.6%) treatment. These numbers were also reflected in the treatment preferences in the presented cases. (Peri)operative management corresponded among responding neurosurgeons. Most respondents would be willing to implement dexamethasone (98%) if equally effective as surgery and tranexamic acid (93%) if effective in CSDH-management. CONCLUSION: Variation was found regarding preferential CSDH-treatment. However, this is considered not to be insurmountable when implementing evidence-based treatments. This baseline inventory on current clinical practice and current attitudes toward CSDH-treatment is a stepping-stone in the eventual development and implementation of a national guideline.
AB - BACKGROUND: Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. However, evidence-based CSDH-guidelines are lacking and level I evidence from randomized clinical trials (RCTs) is limited. In order to establish and subsequently implement a guideline, insight into current clinical practice and attitudes toward CSDH-treatment is required. The aim is to explore current practice and attitudes toward CSDH-management in the Netherlands. METHODS: A national online survey was distributed among Dutch neurologists and neurosurgeons, examining variation in current CSDH-management through questions on treatment options, (peri)operative management, willingness to adopt new treatments and by presenting four CSDH-cases. RESULTS: One hundred nineteen full responses were received (8% of neurologists, N = 66 and 35% of neurosurgeons, N = 53). A majority of the respondents had a positive experience with burr-hole craniostomy (93%) and with a conservative policy (56%). Around a third had a positive experience with the use of dexamethasone as primary (30%) and additional (33.6%) treatment. These numbers were also reflected in the treatment preferences in the presented cases. (Peri)operative management corresponded among responding neurosurgeons. Most respondents would be willing to implement dexamethasone (98%) if equally effective as surgery and tranexamic acid (93%) if effective in CSDH-management. CONCLUSION: Variation was found regarding preferential CSDH-treatment. However, this is considered not to be insurmountable when implementing evidence-based treatments. This baseline inventory on current clinical practice and current attitudes toward CSDH-treatment is a stepping-stone in the eventual development and implementation of a national guideline.
KW - chronic subdural hematoma
KW - guideline
KW - surveys and questionnaires
KW - traumatic brain injury
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85127730091&partnerID=8YFLogxK
U2 - 10.1002/brb3.2463
DO - 10.1002/brb3.2463
M3 - Article
C2 - 35113493
VL - 12
SP - e2463
JO - Brain and behavior
JF - Brain and behavior
SN - 2162-3279
IS - 3
M1 - e2463
ER -
ID: 23054645